Delivery Order SPE2DB22D3011-SPE2DB23FQ3MV
- Not listed
- This federal contract award, valued at $13,933.44, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Trulicity 3 mg/0.5 ml pens, a medication used to manage diabetes. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
- This federal contract award, valued at $7,320.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trulicity 1.5 mg/0.5 ml pens, a medication used to manage diabetes. This is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to...
- This federal contract award, valued at $13,933.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trulicity 3 mg/0.5 ml pens, a medication used for diabetes management. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued...
- This federal contract award, valued at $8,344.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trulicity 3 mg/0.5 ml pens, a medication used to manage diabetes. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This federal contract award, valued at $2,467.36, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trulicity 3 mg/0.5 ml pens, a medication used to treat diabetes. The award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. (doing business as Amerisourcebergen) and the DLA Troop Support Medical, valued at up...
- This federal contract award, valued at $2,280.76, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of Trulicity 1.5 mg/0.5 ml pens, a medication used for diabetes management. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued up to $999,999,999.00, serves as...
- This federal contract award, valued at $2,755.27, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trulicity 1.5 mg/0.5 ml pens, a medication used for diabetes management. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to...
- This federal contract award, valued at $9,332.13, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trulicity 4.5 mg/0.5 ml pens, a medication used to manage diabetes. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This federal contract award, valued at $12,163.67, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of Trulicity 3 mg/0.5 ml pens, a medication used to manage type 2 diabetes. The contract has an ultimate completion date of August 6, 2024. This appears to be a delivery order issued under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
- This federal contract award, valued at $26,996.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trulicity 4.5 mg/0.5 ml pens, a medication used to manage diabetes. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB23FQ3MVDelivery Order
This federal contract award, valued at $11,289.41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Trulicity 3 mg/0.5 ml pens, a medication used to manage diabetes. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The contract does not have a set-aside designation, indicating open competition. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.3k | 9/27/23 |